• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不丹黑热病后皮肤利什曼病的非典型表现

Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan.

作者信息

Pradhan Ambika, Tobgay Tashi, Dorjee Sithar, Wangdi Tenzin, Zhou Guofa, Karunaweera Nadira D

机构信息

Jigmi Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.

Khesar Gyalpo University of Medical Sciences of Bhutan, Thimphu, Bhutan.

出版信息

Case Rep Dermatol Med. 2020 Aug 21;2020:8899586. doi: 10.1155/2020/8899586. eCollection 2020.

DOI:10.1155/2020/8899586
PMID:32904486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7456484/
Abstract

This article describes an atypical case of post-kala-azar dermal leishmaniasis associated with complications due to delayed diagnosis and poor case management. The grave consequences of the prolonged disease process that continued for over 2 decades with eventual healing included facial disfigurement, visual impairment, and mental distress both to the patient and the family. The persistent infection within the skin over a lengthy period with likely increased risk of infection spread in the community highlights its potential negative impact on the ongoing leishmaniasis elimination program in the Indian subcontinent. Bhutan is a member of the leishmaniasis elimination network in Asia, and the government continues to invest in maintenance of the national healthcare system. The case study reveals the gaps in the healthcare system with hardships faced by a patient to access quality healthcare and poor patient outcome used as proxy indicators. It also points to the need to enhance access to healthcare to ensure early diagnosis and effective treatment for leishmaniasis patients including those who live in remote areas, in order to achieve the planned disease elimination targets. It also points towards the key challenges faced by a resource poor nation such as Bhutan in achieving universal health coverage and reaching the set goals for disease elimination. The findings underscore the need for a careful review of the national health care system and to address the deficiencies.

摘要

本文描述了一例黑热病后皮肤利什曼病的非典型病例,该病例因诊断延误和病例管理不善而出现并发症。病程长达20多年最终治愈,其严重后果包括面部毁容、视力损害以及患者和家庭的精神痛苦。皮肤长期持续感染,且在社区中感染传播风险可能增加,这凸显了其对印度次大陆正在进行的利什曼病消除计划的潜在负面影响。不丹是亚洲利什曼病消除网络的成员,政府继续投资维持国家医疗体系。该案例研究揭示了医疗体系中的差距,以患者获得优质医疗服务所面临的困难和不良的患者治疗结果作为代理指标。它还指出,有必要加强医疗服务的可及性,以确保对利什曼病患者,包括那些生活在偏远地区的患者进行早期诊断和有效治疗,从而实现计划的疾病消除目标。它还指出了像不丹这样资源匮乏的国家在实现全民健康覆盖和达到既定疾病消除目标方面面临的关键挑战。这些发现强调了仔细审查国家医疗体系并解决其不足之处的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/7456484/956d65bc703b/CRIDM2020-8899586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/7456484/de430b664cf1/CRIDM2020-8899586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/7456484/956d65bc703b/CRIDM2020-8899586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/7456484/de430b664cf1/CRIDM2020-8899586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/7456484/956d65bc703b/CRIDM2020-8899586.002.jpg

相似文献

1
Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan.不丹黑热病后皮肤利什曼病的非典型表现
Case Rep Dermatol Med. 2020 Aug 21;2020:8899586. doi: 10.1155/2020/8899586. eCollection 2020.
2
Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.Post-Kala-azar 皮肤利什曼病患者对沙蝇的感染力:在印度次大陆消灭黑热病计划的背景下重新验证一个概念。
Clin Infect Dis. 2017 Jul 1;65(1):150-153. doi: 10.1093/cid/cix245.
3
Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission.Post-Kala-Azar Dermal Leishmaniasis 作为内脏利什曼病传播的储主。
Trends Parasitol. 2019 Aug;35(8):590-592. doi: 10.1016/j.pt.2019.06.007. Epub 2019 Jun 29.
4
Immune Responses in Post Kala-azar Dermal Leishmaniasis.黑热病后皮肤利什曼病中的免疫反应
Indian J Dermatol. 2020 Nov-Dec;65(6):452-460. doi: 10.4103/ijd.IJD_258_20.
5
Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.巴西一名患者的皮肤利什曼病:病例报告
Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):105-107. doi: 10.1590/0037-8682-0487-2016.
6
Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.黑热病后皮肤利什曼病的组织病理学特征:88例患者系列研究
Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):29-34. doi: 10.4103/0378-6323.148562.
7
Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.利用重点药物警戒确保孟加拉国国家黑热病消除规划中抗利什曼原虫药物的患者安全。
Infect Dis Poverty. 2018 Aug 13;7(1):80. doi: 10.1186/s40249-018-0461-0.
8
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.定量评估卡拉巴肿后皮肤利什曼病对沙蝇的感染性。
Clin Infect Dis. 2019 Jul 2;69(2):251-258. doi: 10.1093/cid/ciy891.
9
Challenges for management of post kala-azar dermal leishmaniasis and future directions.黑热病后皮肤利什曼病的管理挑战及未来方向
Res Rep Trop Med. 2014 Nov 14;5:105-111. doi: 10.2147/RRTM.S35707. eCollection 2014.
10
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.接受注射用抗利什曼原虫药物治疗的印度黑热病患者中的乙型和丙型肝炎病毒感染:一项基于社区的研究。
Int J Infect Dis. 2000;4(4):203-8. doi: 10.1016/s1201-9712(00)90110-3.

引用本文的文献

1
Is Leishmaniasis donovani elimination feasible in Bhutan? A review of current prevention and control mechanisms in Bhutan.在不丹消除杜氏利什曼原虫病是否可行?对不丹当前预防和控制机制的综述。
Bhutan Health J. 2020 Nov;6(2):27-30. doi: 10.47811/bhj.106. Epub 2021 Jun 4.
2
Efforts toward the Elimination of Visceral Leishmaniasis in South Asia: A Review of Progress in Bhutan.南亚消除内脏利什曼病的努力:不丹进展综述。
Am J Trop Med Hyg. 2024 Mar 12;110(4):633-638. doi: 10.4269/ajtmh.23-0642. Print 2024 Apr 3.
3
Unusual Observations in Leishmaniasis-An Overview.

本文引用的文献

1
Biomarkers in Post-kala-azar Dermal Leishmaniasis.Post-kala-azar Dermal Leishmaniasis 中的生物标志物。
Front Cell Infect Microbiol. 2019 Jul 31;9:228. doi: 10.3389/fcimb.2019.00228. eCollection 2019.
2
Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.印度次大陆的黑热病后皮肤利什曼病:对东南亚区域消除黑热病规划的一个威胁
PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877. doi: 10.1371/journal.pntd.0005877. eCollection 2017 Nov.
3
Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
利什曼病的异常观察——概述
Pathogens. 2023 Feb 10;12(2):297. doi: 10.3390/pathogens12020297.
Post-Kala-azar 皮肤利什曼病患者对沙蝇的感染力:在印度次大陆消灭黑热病计划的背景下重新验证一个概念。
Clin Infect Dis. 2017 Jul 1;65(1):150-153. doi: 10.1093/cid/cix245.
4
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.印度慢性砷暴露与黑热病后皮肤利什曼病发生风险:一项回顾性队列研究
PLoS Negl Trop Dis. 2016 Oct 24;10(10):e0005060. doi: 10.1371/journal.pntd.0005060. eCollection 2016 Oct.
5
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.过去二十年印度黑热病后皮肤利什曼病(PKDL)病例的临床流行病学分析:一项基于医院的回顾性研究
BMC Public Health. 2015 Oct 26;15:1092. doi: 10.1186/s12889-015-2424-8.
6
Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine.伴有黏膜受累的黑热病后皮肤利什曼病:一例罕见病例报告,包括米替福新治疗成功。
J Health Popul Nutr. 2013 Jun;31(2):294-7. doi: 10.3329/jhpn.v31i2.16395.
7
Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern.内脏利什曼病和卡拉·阿扎尔后皮肤利什曼病分离株的体外药物敏感性模式存在显著差异。
Parasitol Res. 2013 Mar;112(3):1001-9. doi: 10.1007/s00436-012-3222-1. Epub 2012 Dec 18.
8
Endemic transmission of visceral leishmaniasis in Bhutan.不丹内脏利什曼病的地方性传播。
Am J Trop Med Hyg. 2012 Dec;87(6):1028-37. doi: 10.4269/ajtmh.2012.12-0211. Epub 2012 Oct 22.
9
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010).尼泊尔的黑热病后皮肤利什曼病:一项回顾性队列研究(2000-2010 年)。
PLoS Negl Trop Dis. 2011 Dec;5(12):e1433. doi: 10.1371/journal.pntd.0001433. Epub 2011 Dec 20.
10
Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.内脏利什曼病后的失明:一种被忽视的黑热病后并发症。
Trop Doct. 2011 Jul;41(3):139-40. doi: 10.1258/td.2011.110058. Epub 2011 Jun 15.